WA HB2677

Medicaid must cover FDA-approved seizure detection devices as durable medical equipment effective January 1, 2026, when deemed medically appropriate and prescribed by a health care provider

Coverage applies when devices would likely reduce bodily harm or death from seizures, or provide data necessary to diagnose or treat conditions causing seizure activity

Full coverage required for the device and any related service or subscription, with subscription reimbursement set at 100 percent of the monthly remote monitoring rate under the telemonitoring benefit

The Health Care Authority must conduct biennial reviews of covered seizure detection devices and update the list to include the latest FDA-approved technologies

Seizure detection devices are defined as FDA-approved monitoring devices that detect seizure activity, transmit alerts to caregivers, or collect seizure data for diagnostic purposes